Status:
COMPLETED
Silver Doped Ceramic Coated Orthopedic Implants
Lead Sponsor:
Eskisehir Osmangazi University
Conditions:
Implant Site Infection
Implant Infection
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this study, CE (European Conformity) marked, domestic manufactured standard orthopedic implants will be used after silver HA coating with electrospray method in 30 patients requiring hip joint pros...
Detailed Description
In this study, considering the differences in bone contact surface area and interactions; hip joint prostheses, intramedullary nails and external fixator implants to be used in 30 patients . CE (Europ...
Eligibility Criteria
Inclusion
- Men and women between the ages of 18-65
- Patients without heart, lung, renal or hepatic insufficiency
- Patients without epilepsy, cerebrovascular attack or ischaemia
- Patients without antibiotic allergy
- Patients who have low immune defense mechanisms such as malignancy, diabetes mellitus, polytrauma, and open fracture
- Patients using oral or parenteral corticosteroids, methotrexate, cyclosporine or other immunosuppressive drugs - -
Exclusion
- Pregnant women
- Patients with another silver implant in their body, such as a silver-coated stent
- Patients with known allergy or hypersensitivity to silver
- Patients with too many antibiotics due to recurrent infections
Key Trial Info
Start Date :
March 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03343288
Start Date
March 15 2017
End Date
March 15 2020
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskisehir Osmangazi University Hospital
Eskişehir, Turkey (Türkiye), 26480